Capsida to Present Progress Updates on CAP-002 at the ASGCT Annual Meeting
STXBP1 Census - Q1 2025
Small Town. Loud Voice.
What happens when a rare disease drug seems to work, but the health care system doesn’t?
Orphan Disease Center 2024 Million Dollar Bike Ride Grants - $139,416 for STXBP1 Research Awarded
STXBP1 Foundation Accelerates Growth with Addition of New Executive Director
STXBP1 Census - Q4 2024
Capsida Biotherapeutics granted orphan drug designation for potential gene therapy for STXBP1-related disorders
FDA Grants Orphan Drug Designation to Capsida Biotherapeutics for Potential Treatment of STXBP1 Developmental and Epileptic Encephalopathy